FI119987B - Menetelmä uusien substituoitujen oksatsolidiinien valmistamiseksi - Google Patents

Menetelmä uusien substituoitujen oksatsolidiinien valmistamiseksi Download PDF

Info

Publication number
FI119987B
FI119987B FI962341A FI962341A FI119987B FI 119987 B FI119987 B FI 119987B FI 962341 A FI962341 A FI 962341A FI 962341 A FI962341 A FI 962341A FI 119987 B FI119987 B FI 119987B
Authority
FI
Finland
Prior art keywords
formula
compound
compounds
process according
salt
Prior art date
Application number
FI962341A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI962341A0 (fi
FI962341A (fi
Inventor
Alfred Sallmann
Eric Francotte
Hans-Peter Gschwind
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of FI962341A0 publication Critical patent/FI962341A0/fi
Publication of FI962341A publication Critical patent/FI962341A/fi
Application granted granted Critical
Publication of FI119987B publication Critical patent/FI119987B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI962341A 1993-12-10 1996-06-05 Menetelmä uusien substituoitujen oksatsolidiinien valmistamiseksi FI119987B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH369193 1993-12-10
CH369193 1993-12-10
PCT/EP1994/003937 WO1995015953A1 (en) 1993-12-10 1994-11-28 Novel substituted oxazolidines
EP9403937 1994-11-28

Publications (3)

Publication Number Publication Date
FI962341A0 FI962341A0 (fi) 1996-06-05
FI962341A FI962341A (fi) 1996-06-05
FI119987B true FI119987B (fi) 2009-05-29

Family

ID=4261454

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962341A FI119987B (fi) 1993-12-10 1996-06-05 Menetelmä uusien substituoitujen oksatsolidiinien valmistamiseksi

Country Status (14)

Country Link
US (1) US5635524A (ja)
EP (1) EP0733047B1 (ja)
JP (1) JP3792713B2 (ja)
KR (1) KR100354528B1 (ja)
AT (1) ATE171169T1 (ja)
AU (1) AU692809B2 (ja)
CA (1) CA2177171C (ja)
DE (1) DE69413417T2 (ja)
ES (1) ES2121621T3 (ja)
FI (1) FI119987B (ja)
HU (1) HU221500B (ja)
NO (1) NO306463B1 (ja)
NZ (1) NZ276421A (ja)
WO (1) WO1995015953A1 (ja)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064257A (en) * 1976-07-19 1977-12-20 Syntex (U.S.A.) Inc. Thiazole cardiovascular agents
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
TW209832B (ja) * 1989-10-10 1993-07-21 Glaxo Group Ltd

Also Published As

Publication number Publication date
WO1995015953A1 (en) 1995-06-15
US5635524A (en) 1997-06-03
JP3792713B2 (ja) 2006-07-05
AU692809B2 (en) 1998-06-18
CA2177171C (en) 2006-01-17
NO962424L (no) 1996-06-07
HU221500B (en) 2002-10-28
EP0733047A1 (en) 1996-09-25
KR100354528B1 (ko) 2002-12-18
DE69413417T2 (de) 1999-03-04
FI962341A0 (fi) 1996-06-05
NO962424D0 (no) 1996-06-07
ATE171169T1 (de) 1998-10-15
ES2121621T3 (es) 1998-12-01
EP0733047B1 (en) 1998-09-16
NO306463B1 (no) 1999-11-08
HU9601585D0 (en) 1996-08-28
HUT74689A (en) 1997-01-28
CA2177171A1 (en) 1995-06-15
NZ276421A (en) 1998-01-26
DE69413417D1 (de) 1998-10-22
AU1068395A (en) 1995-06-27
FI962341A (fi) 1996-06-05
JPH09506357A (ja) 1997-06-24

Similar Documents

Publication Publication Date Title
AU626949B2 (en) 2-amino-4 or 5-methoxycyclohexyl amides useful as analgesics
FI88030B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva fenoxiaettiksyraderivat
JPH11503449A (ja) タキキニン受容体アンタゴニスト活性を有する新規な置換されたピペラジン誘導体
RU2114108C1 (ru) ПРОИЗВОДНЫЕ 7-(2-АМИНОЭТИЛ)БЕНЗОТИАЗОЛОНА ИЛИ ИХ ФАРМАЦЕВТИЧЕСКИ ПРИЕМЛЕМЫЕ СОЛИ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, ПРОИЗВОДНЫЕ N-[2-(4-ГИДРОКСИ-2-ОКСО-3H-1,3-БЕНЗОТИАЗОЛ-7-ИЛ)ЭТИЛАМИДА]ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ПРОЯВЛЯЮЩАЯ АГОНИСТИЧЕСКУЮ АКТИВНОСТЬ В ОТНОШЕНИИ β2-АДРЕНОРЕЦЕПТОРОВ
JPS6259101B2 (ja)
JPH0569817B2 (ja)
HU204767B (en) Process for producing 1-phenyl-3-naphthyloxy propylamines and pharmaceutical compositions comprising such compounds
US20110028442A1 (en) Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the beta2 adrenergic receptor
NO128653B (ja)
EP0787716B1 (en) Isoprene derivatives
JPH03133946A (ja) フェンエタノールアミン化合物
US3949088A (en) Substituted phenoxy propanol amines used for treating cardiovascular diseases
FI119987B (fi) Menetelmä uusien substituoitujen oksatsolidiinien valmistamiseksi
KR101398775B1 (ko) 아세트아미드 입체이성체
AU672984B2 (en) Novel oxazolidines
AU691619B2 (en) Substituted alkyldiamine derivatives and their use as tachykinin antagonists
AU618171B2 (en) New bronchospasmolytic compounds and process for their preparation
FI67075B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara disubstituerade fenoletrar av 3-amino-2-hydroxipropan och salter daerav
CA1246083A (en) Ethanolamines
JPH0372448A (ja) 化合物
WO1999009001A1 (fr) Derives de phenylethanolaminotetraline et bronchodilatateurs
GB2151228A (en) Organic compounds and their pharmaceutical use
JPS62126179A (ja) ４−アシルレゾルシンエ−テル、その製法およびそれを含む薬剤

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FG Patent granted

Ref document number: 119987

Country of ref document: FI

MA Patent expired